Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy 2021-01-19 14:05
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy 2021-01-18 22:00
TenNor Enters Research Collaboration with Janssen for Potential New Treatments for Nontuberculous Mycobacteria Diseases 2021-01-18 21:00
Gracell Biotechnologies Receives Medical Products Manufacturing Certificate for CAR-T Cell Therapy Products 2021-01-15 21:00
ATIF Holdings Limited Announces Its IPO Client Soars 100% in the U.S. Trading Debut 2021-01-13 21:00
China NMPA Grants Approval for the Registrational Phase 1/2 Clinical Study for GC007g - an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL 2021-01-13 21:00
Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma 2021-01-11 22:00
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China 2021-01-09 11:06
Gracell Biotechnologies Announces Pricing of Initial Public Offering 2021-01-08 14:55
Bioworkshops successfully passed EU QP audit 2021-01-06 22:00
PharmAbcine to participate in BIO @ JPM and Biotech Showcase Digital during "J.P. Morgan Week 2021" 2021-01-04 21:00
ImmVira Announces Series C Financing with Leading Specialist Investors 2020-12-31 19:29
Yuyu Pharma was recognized as "Family-Friendly Company" by the Ministry of Gender Equality and Family 2020-12-30 22:00
Arctic Vision obtains the first IND approval for the treatment of UME in China, Suprachoroidal space (SCS) injection potentially brings more benefits to patients 2020-12-25 21:00
Foresee Pharmaceuticals Announces Completion of US$47 Million Financing 2020-12-24 18:00
Senhwa Biosciences Receives US FDA 'Study May Proceed' Letter to Treat BRCA2+ or PALB2+ Solid Tumors With CX-5461 2020-12-24 10:40
Conbercept: New Generation of Product for Treatment of nAMD Completes 36-week Primary Endpoint Visits of Phase III Trial 2020-12-23 22:40
I-Mab Announces Upcoming Participation at January Conferences 2020-12-23 21:00
Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19 2020-12-23 10:09
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004 2020-12-21 23:00
1 111 112 113 114 115 165